Jose Martinez, DO
Rheumatology · Altamonte Springs, FLNPI 1043654775
Payments from drug & device makers
Across 603 payments — averaging $132.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$68K
- UCB, Inc.$3K
- Pfizer$2K
- Amgen$2K
- Novartis$620
- Lilly USA, LLC$573
- plus $3K from 20 others
What the payments were for
- Consulting fees$3,5155%
- Speaking & faculty fees$55,80078%
- Travel & lodging$1,5662%
- Food & beverage$10,79115%
- Education$2200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 144 | $68,158 |
| UCB, Inc. | 91 | $3,112 |
| Pfizer | 36 | $2,366 |
| Amgen(2 entities) | 117 | $2,149 |
| Novartis | 33 | $620 |
| Lilly USA, LLC | 32 | $573 |
| GSK | 28 | $482 |
| Johnson & Johnson(2 entities) | 23 | $420 |
| Mallinckrodt Hospital Products Inc. | 15 | $316 |
| E.r. Squibb & Sons, L.L.C. | 11 | $251 |
| AstraZeneca | 13 | $246 |
| Genentech USA, Inc. | 14 | $223 |
| Abbott | 2 | $215 |
| Radius Health, Inc. | 8 | $176 |
| ANI Pharmaceuticals, Inc. | 8 | $166 |
| Sanofi | 8 | $159 |
| Sobi, Inc | 9 | $154 |
| Medtronic | 1 | $93 |
| Bristol Myers Squibb | 2 | $35 |
| Boehringer Ingelheim | 2 | $34 |
| Fresenius Kabi USA, LLC | 1 | $29 |
| Mallinckrodt Enterprises LLC | 1 | $27 |
| Boston Scientific | 1 | $26 |
| Medline Industries LP | 1 | $14 |
| Antares Pharma, Inc. | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$80,067 in reported general payments places this provider in the 75th percentile of 453 rheumatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 49 | $924 |
| Prednisone | 161 | $830 |
| Leflunomide | 17 | $650 |
| Gabapentin | 48 | $618 |
| Diclofenac Sodium | 64 | $584 |
| Hydroxychloroquine Sulfate | 45 | $522 |
| Celecoxib | 25 | $446 |
| Colchicine | 15 | $404 |
| Pregabalin | 13 | $277 |
| Baclofen | 14 | $178 |
| Cyclobenzaprine Hcl | 25 | $125 |
| Sulfasalazine | 12 | $79 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Altamonte Springs
- Martha Hernandez IllasFort Lauderdale$25M
- Carlos SesinMiami Beach$19M
- Guillermo ValenzuelaPlantation$14.2M
- Marimer Rensoli VelazquezMiami$12.2M
- Robert LevinClearwater$11M
- Jigar ShahMargate$5.6M
- Michael BubbGainesville$3.3M
- Vipul JoshiBrandon$3.1M
- Alvin WellsDestin$2.9M
- Benidecto FernandezHialeah$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.